Inspire Medical Systems, Inc. INSP
Institutional shares held
27.6 Million
519K
calls
590K
puts
Total value of holdings
$5.29B
$99.3M
calls
$113M
puts
Market Cap
$5.56B
28,788,600
Shares Out.
Institutional ownership
95.91%
# of Institutions
398
We take great care to ensure that the data presented and summarized in this overview for Inspire Medical Systems, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding INSP
View all-
Vanguard Group Inc Valley Forge, PA3.23MShares$624 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.86MShares$359 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA1.39MShares$269 Million0.05% of portfolio
-
Baillie Gifford & CO1.37MShares$264 Million0.22% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.32MShares$255 Million1.39% of portfolio
-
State Street Corp Boston, MA1.05MShares$203 Million0.01% of portfolio
-
William Blair Investment Management, LLC Chicago, IL906KShares$175 Million0.49% of portfolio
-
Jpmorgan Chase & CO New York, NY742KShares$143 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA694KShares$134 Million0.03% of portfolio
-
Macquarie Group LTD Australia, C3582KShares$112 Million0.14% of portfolio
Latest Institutional Activity in INSP
Top Purchases
Top Sells
About INSP
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Insider Transactions at INSP
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 01
2024
|
John Rondoni Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
8,703
-12.68%
|
$1,688,382
$194.53 P/Share
|
|
Nov 01
2024
|
John Rondoni Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,703
+18.96%
|
$487,368
$56.58 P/Share
|
|
Oct 14
2024
|
Gary Lee Ellis Director |
BUY
Grant, award, or other acquisition
|
Direct |
115
+2.61%
|
$24,150
$210.46 P/Share
|
|
Oct 14
2024
|
Georgia Melenikiotou Director |
BUY
Grant, award, or other acquisition
|
Direct |
79
+3.45%
|
$16,590
$210.46 P/Share
|
|
Oct 14
2024
|
Casey M Tansey Director |
BUY
Grant, award, or other acquisition
|
Direct |
68
+0.33%
|
$14,280
$210.46 P/Share
|
|
Oct 14
2024
|
Shelley G. Broader Director |
BUY
Grant, award, or other acquisition
|
Direct |
77
+2.99%
|
$16,170
$210.46 P/Share
|
|
Sep 09
2024
|
John Rondoni Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
31
-0.27%
|
$6,665
$215.0 P/Share
|
|
Sep 09
2024
|
Shawn Mc Cormick Director |
SELL
Open market or private sale
|
Direct |
800
-3.34%
|
$176,000
$220.0 P/Share
|
|
Aug 22
2024
|
John Rondoni Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
5,000
-16.18%
|
$945,000
$189.6 P/Share
|
|
Aug 22
2024
|
John Rondoni Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+23.39%
|
$355,000
$71.0 P/Share
|
|
Aug 16
2024
|
Randy Ban Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
4,861
-25.9%
|
$913,868
$188.47 P/Share
|
|
Aug 16
2024
|
Randy Ban Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,861
+38.04%
|
$204,162
$42.15 P/Share
|
|
Aug 15
2024
|
Randy Ban Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
16,139
-22.8%
|
$3,098,688
$192.1 P/Share
|
|
Aug 15
2024
|
Randy Ban Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,139
+45.68%
|
$677,838
$42.15 P/Share
|
|
Aug 14
2024
|
Shawn Mc Cormick Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,537
+26.29%
|
$0
$0.94 P/Share
|
|
Jul 31
2024
|
Melissa Mann Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,190
+50.0%
|
-
|
|
Jul 15
2024
|
Shelley G. Broader Director |
BUY
Grant, award, or other acquisition
|
Direct |
117
+4.61%
|
$16,146
$138.58 P/Share
|
|
Jul 15
2024
|
Gary Lee Ellis Director |
BUY
Grant, award, or other acquisition
|
Direct |
154
+3.56%
|
$21,252
$138.58 P/Share
|
|
Jul 15
2024
|
Georgia Melenikiotou Director |
BUY
Grant, award, or other acquisition
|
Direct |
32
+1.48%
|
$4,416
$138.58 P/Share
|
|
Jul 15
2024
|
Casey M Tansey Director |
BUY
Grant, award, or other acquisition
|
Direct |
103
+0.5%
|
$14,214
$138.58 P/Share
|
Last 12 Months Summary
Buy / Acquisition
144K
Shares
From
25
Insiders
| Grant, award, or other acquisition | 39.3K shares |
|---|---|
| Exercise of conversion of derivative security | 104K shares |
| Bona fide gift | 500 shares |
Sell / Disposition
125K
Shares
From
10
Insiders
| Bona fide gift | 3.56K shares |
|---|---|
| Open market or private sale | 121K shares |
| Payment of exercise price or tax liability | 205 shares |